Trial intelligence / Profile preview

PAC-14028 Cream in Facial Seborrheic Dermatitis

NCT02749383Phase 2Completed

Sponsor
Amorepacific Corporation
Start
Feb 2014
Primary completion
Dec 2014
Modality
Small Molecules, Drug Delivery Systems
01

Overview

A Phase 2 trial of asivatrep in seborrheic dermatitis (SD), sponsored by Amorepacific Corporation. Started Feb 2014; status: completed.

02

Drugs

asivatrep
03

Conditions

seborrheic dermatitis (SD)

Beyond the preview

Go deeper on NCT02749383.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02749383.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call